Rahul purwar
Indian Institute of Technology Bombay
H-index: 16
Asia-India
Top articles of Rahul purwar
IL-17A Orchestrates Reactive Oxygen Species/HIF1α–Mediated Metabolic Reprogramming in Psoriasis
The Journal of Immunology
2024/1/15
IL-17A Orchestrates Reactive Oxygen Species/HIF1a− Mediated Metabolic Reprogramming in Psoriasis
Skin
2024
CAR‐T cell therapy in hematological malignancies: Where are we now and where are we heading for?
2024/1
Rahul Purwar
H-Index: 10
Evaluating the Safety of HCAR19 (Now Actalycabtagene Autoleucel-Actaly-Cel™), a Novel Humanized CD19-Directed Chimeric Antigen Receptor T-Cells in Pediatric, Adolescents, and …
Blood
2023/12/1
Excellent Safety Profile of a Low-Cost Novel Humanized CD19 CAR T-Cell Therapy, Actalycabtagene Autoleucel: Potential Impact on Access and Feasibility
Blood
2023/11/28
High Efficacy and Excellent Safety Profile of Actalycabtagene Autoleucel, a Humanized CD19 CAR-T Product in r/r B-Cell Malignancies: A Phase II Pivotal Trial
Blood
2023/11/28
Atharva Karulkar
H-Index: 3
Neha Sharma
H-Index: 1
Yash Jain
H-Index: 0
Sanjay Biswas
H-Index: 5
Rahul Purwar
H-Index: 10
Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option
2023/3/15
127 IL-17 acts as the master regulator for metabolic rewiring in skin inflammation and drives keratinocytes towards a hyperproliferative phenotype
Journal of Investigative Dermatology
2022/8/1
062 High-throughput quantitative proteomics unveils HIF1α as a driver of IL17A-induced metabolic alterations favoring hyperproliferation in keratinocytes
Journal of Investigative Dermatology
2022/8/1
Genetic alterations and oxidative stress in T cell lymphomas
2022/8/1
Sushant Kumar
H-Index: 3
Rahul Purwar
H-Index: 10
Immunogenicity of CAR-T cell therapeutics: evidence, mechanism and mitigation
2022/5/23
Phase I trial of humanized CD19 CART-cell therapy developed in India: safe, active and feasible for outpatient therapy
Blood
2022/11/15
Making anti-CD19 CAR-T cell therapy accessible and affordable: first-in-human phase I clinical trial experience from India
Blood
2022/11/15
Transcriptional Fluctuations Govern the Serum-Dependent Cell Cycle Duration Heterogeneities in Mammalian Cells
ACS Synthetic Biology
2022/11/3
Atharva Karulkar
H-Index: 3
Rahul Purwar
H-Index: 10
Clinical utility of CAR T cell therapy in brain tumors: Lessons learned from the past, current evidence and the future stakes
2022/10/21
Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds
2022/10/21
Abhishek Chatterjee
H-Index: 20
Sandhya Yadav
H-Index: 3
Atharva Karulkar
H-Index: 3
Rahul Purwar
H-Index: 10
Presence and the roles of IL‐9/Th9 axis in vitiligo
Pigment Cell & Melanoma Research
2021/9
Multiomics analysis and systems biology integration identifies the roles of IL-9 in keratinocyte metabolic reprogramming
Journal of Investigative Dermatology
2021/8/1
IL-9 Abrogates the metastatic potential of breast cancer by controlling extracellular matrix remodeling and cellular contractility
The Journal of Immunology
2021/6/1
Robust antitumor activity and low cytokine production by novel humanized anti-CD19 CAR T cells
Molecular Cancer Therapeutics
2021/5/1
Co-Authors
